23 February 2012
An innovative microfluidic device being developed in the US could advance cancer diagnosis and treatment.
Sukant Mittal and colleagues from the Massachusetts Institute of Technology are the minds behind the new gadget, which is able to isolate dangerous target cells at a quicker rate than current technology.
As such, medical professionals could soon be able to search for signs of tumour cells, stem cells or fetal cells in a body more efficiently in the near future.
Mr Mittal believes the device has the means to advance the medical industry, seeing as though the designs of current gadgets mean that physicians are "basically looking for a needle in a haystack".
Mehmet Toner, a professor of biomedical engineering, has also worked on the device, and commented: "This novel approach may enable exciting diagnostic and therapeutic opportunities that are not feasible using existing technologies."
Researchers at Cardiff University and King's College London have conducted their own study, which highlights that zinc can play a pivotal part in combating the cells which lead to the development of aggressive breast cancer.
Posted by Edward Bartel
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.